Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases Read more
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat technology Read more
Incyte announces validation by EMA of its MAA for pemigatinib in patients with cholangiocarcinoma Read more